Physician

Igor Matthew Cherches, M.D.

According to 2025 Medicare claims, Igor Cherches, M.D. (NPI: 1942295522) practices neurology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP GULF COAST, PLLC (NPI: 1578969465; TIN: 462456505) and primary practice location at 77030-1341. Cherches is affiliated with the Privia Quality Network Gulf Coast II, LLC (ACO ID: A3783), Main Street Rural Health Hickory ACO LLC (ACO ID: A5334), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Cherches' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 921 traditional Medicare patients, billed 274,246 HCPCS/CPT codes, and received $12,582,950 in Medicare payments. The top billing code was 95912 (Nerve conduction, 11-12 studies). Part D data shows 3,770 prescription claims across 620 beneficiaries totaling $1,049,949 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). 2015 DME data shows 24 claims. Open Payments data shows 200 records totaling $6,697. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,393,762 to $12,582,950. In contrast, Part D prescription costs have declined steadily, from $1,586,335 to $1,049,949. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	741	50,495	$1,393,762
2016	695	49,580	$1,529,127
2017	747	54,251	$1,830,365
2018	739	68,686	$3,738,601
2019	764	100,129	$4,990,215
2020	659	125,402	$5,402,831
2021	735	121,633	$5,607,142
2022	851	145,729	$5,811,420
2023	921	208,636	$9,075,517
2024	921	274,246	$12,582,950

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	377	3,137	$1,586,335
2016	401	3,106	$1,624,149
2017	506	3,780	$1,631,856
2018	506	3,760	$1,703,380
2019	518	3,879	$1,627,557
2020	538	4,033	$1,441,223
2021	569	4,040	$1,061,657
2022	580	3,859	$1,012,551
2023	627	3,784	$1,168,506
2024	620	3,770	$1,049,949

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$381
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95912	Nerve conduction, 11-12 studies	272	273	$180
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	323	323	$173
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	394	534	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	252	332	$92
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	517	1,154	$75

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	41	1,127	$239,030
Gammaked	Immune Globul G/Gly/Iga Avg 46	14	308	$212,724
Vumerity	Diroximel Fumarate	12	360	$100,907
Glatiramer Acetate	Glatiramer Acetate	14	392	$39,070
Rasagiline Mesylate	Rasagiline Mesylate	326	17,069	$36,441

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	200	$6,697	Amneal Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Igor Matthew Cherches, M.D.?

Tedicare shows public-source Medicare data for Igor Matthew Cherches, M.D. (NPI 1942295522), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Igor Matthew Cherches, M.D. have ACO affiliation data?

Igor Matthew Cherches, M.D. is shown with ACO affiliation data for Privia Quality Network Gulf Coast II, LLC (MSSP, ACO ID A3783), Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Igor Matthew Cherches, M.D.?

Igor Matthew Cherches, M.D. is linked to PRIVIA MEDICAL GROUP GULF COAST, PLLC (billing NPI 1578969465) in the available physician profile data.

Does Igor Matthew Cherches, M.D. have Open Payments data?

Igor Matthew Cherches, M.D. has 200 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.